Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors
Authors:
- Hui LiuHLHui Liu
- Cornelis BlauwendraatCBCornelis Blauwendraat
- Alastair NoyceANAlastair Noyce
- Isabelle FooteIFIsabelle Foote
- Manu SharmaMSManu Sharma
- International Parkinson's Disease Genomics Consortium; Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease ConsortiumICInternational Parkinson's Disease Genomics Consortium; Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease Consortium
Open Access
- 24 June 2022
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 92 (2) , 270-278
Abstract
Objective: The aim of the current study is to understand why some individuals avoid developing Parkinson disease (PD) despite being at relatively high genetic risk, using the largest datasets of individual‐level genetic data available.Methods: We calculated polygenic risk score to identify controls and matched PD cases with the highest burden of genetic risk for PD in the discovery cohort (International Parkinson's Disease Genomics Consortium, 7,204 PD cases and 9,412 controls) and validation cohorts (Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease, 8,968 cases and 7,598 controls; UK Biobank, 2,639 PD cases and 14,301 controls; Accelerating Medicines Partnership–Parkinson's Disease Initiative, 2,248 cases and 2,817 controls). A genome‐wide association study meta‐analysis was performed on these individuals to understand genetic variation associated with resistance to disease. We further constructed a polygenic resilience score, and performed multimarker analysis of genomic annotation (MAGMA) gene‐based analyses and functional enrichment analyses.Results: A higher polygenic resilience score was associated with a lower risk for PD (β = −0.054, standard error [SE] = 0.022, p = 0.013). Although no single locus reached genome‐wide significance, MAGMA gene‐based analyses nominated TBCA as a putative gene. Furthermore, we estimated the narrow‐sense heritability associated with resilience to PD (h2 = 0.081, SE = 0.035, p = 0.0003). Subsequent functional enrichment analysis highlighted histone methylation as a potential pathway harboring resilience alleles that could mitigate the effects of PD risk loci.Interpretation: The present study represents a novel and comprehensive assessment of heritable genetic variation contributing to PD resistance. We show that a genetic resilience score can modify the penetrance of PD genetic risk factors and therefore protect individuals carrying a high‐risk genetic burden from developing PD. ANN NEUROL 2022;92:270–278Keywords
This publication has 32 references indexed in Scilit:
- Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseasesNature Biotechnology, 2016
- Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling studyThe Lancet Neurology, 2015
- Genetic risk and age in Parkinson's disease: Continuum not stratumMovement Disorders, 2015
- Second-generation PLINK: rising to the challenge of larger and richer datasetsGigaScience, 2015
- Hypothetical geneC18orf42encodes a novel protein kinase A-binding proteinGenes to Cells, 2015
- LD Score regression distinguishes confounding from polygenicity in genome-wide association studiesNature Genetics, 2015
- Role of protein kinase A in regulating mitochondrial function and neuronal development: implications to neurodegenerative diseasesReviews in the Neurosciences, 2015
- Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in bloodActa Neuropathologica, 2013
- METAL: fast and efficient meta-analysis of genomewide association scansBioinformatics, 2010
- Parkinson's disease: from monogenic forms to genetic susceptibility factorsHuman Molecular Genetics, 2009